SCHEMBL8649232

SCHEMBL8649232

Cc1ccc(S(=O)(=O)OCCC2COc3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
HTR2C P28335 1/20 0.41
KCNH2 Q12809 1/20 0.41
FFAR1 O14842 2/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
FFAR4 Q5NUL3 1/20 0.40
POLB P06746 1/20 0.39
HTR6 P50406 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA9 Q16790 1/20 0.37
CYP19A1 P11511 1/20 0.36
CYP24A1 Q07973 1/20 0.36
BDKRB1 P46663 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966432 0.80 LMNA (0.61) LMNASMN1; SMN2POLBCA1CA9
SCHEMBL8787797 0.79 LMNA (0.43) LMNASMN1; SMN2HTR2CKCNH2FFAR1
SCHEMBL9690306 0.78 LMNA (0.42) LMNASMN1; SMN2POLB
SCHEMBL8344592 0.76 ALDH1A1 (0.46) LMNAHTR6BDKRB1
SCHEMBL8647038 0.75 HTR6 (0.36) LMNASMN1; SMN2FFAR4HTR6CA12
SCHEMBL6004127 0.75 VDR (0.46) LMNAFFAR4POLBHTR6CA12
SCHEMBL2098311 0.74 KMT2A (0.49) LMNASMN1; SMN2CA12CA1CA9
SCHEMBL4065055 0.74 KMT2A (0.49) LMNASMN1; SMN2CA12CA1CA9
SCHEMBL6221876 0.74 KMT2A (0.49) LMNASMN1; SMN2CA12CA1CA9
SCHEMBL1866143 0.73 CA12 (0.42) CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5763444-A CENTRAL NERVOUS SYSTEM AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-06-09 US disclosed
EP-0761666-A2 Antidepressant 1-arylalkyl-4-(alkoxypyridinyl)- or 4-(alkoxypyrimidinyl)piperazine derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 1997-03-12 EP disclosed